Graph Convolutional Neural Networks for Predicting Drug-Target Interactions
Open accessPublished version of a preprint
Abstract
Accurate determination of target-ligand interactions is crucial in the drug discovery process. In this paper, we propose a graph-convolutional (Graph-CNN) framework for predicting protein-ligand interactions. First, we built an unsupervised graph-autoencoder to learn fixed-size representations of protein pockets from a set of representative druggable protein binding sites. Second, we trained two Graph-CNNs to automatically extract features from pocket graphs and 2D ligand graphs, respectively, driven by binding classification labels. We demonstrate that graph-autoencoders can learn fixed-size representations for protein pockets of varying sizes and the Graph-CNN framework can effectively capture protein-ligand binding interactions without relying on target-ligand complexes. Across several metrics, Graph-CNNs achieved better or comparable performance to 3DCNN ligand-scoring, AutoDock Vina, RF-Score, and NNScore on common virtual screening benchmark data sets. Visualization of key pocket residues and ligand atoms contributing to the classification decisions confirms that our networks are able to detect important interface residues and ligand atoms within the pockets and ligands, respectively.
AI snapshot
Written from the paper’s full text.
TL;DR
The paper proposes a two-stage graph-convolutional framework that first learns fixed-size protein-pocket representations with an unsupervised graph autoencoder and then trains parallel Graph-CNNs on pocket graphs and 2D molecular graphs to predict drug-target binding without requiring co-crystal complexes. Across DUD-E and MUV benchmarks, the model achieves better or comparable performance to 3DCNN ligand-scoring, AutoDock Vina, RF-Score, and NNScore.
Key findings
- On DUD-E, Graph-CNN achieved AUC 0.886 versus 3DCNN 0.868, Vina 0.716, RF-Score 0.622, and NNScore 0.584; at 0.5% FPR, RE was 44.406 versus 42.559, 9.139, 5.628, and 4.166, respectively.
- On the independent MUV dataset, Graph-CNN achieved average AUC 0.563 versus 3DCNN 0.518, Vina 0.545, RF-Score 0.497, and NNScore 0.430; Graph-CNN attained AUC > 0.6 for 5 of 8 MUV targets, while Vina, 3DCNN, RF-Score, and NNScore had no more than two such targets.
- A five-fold MUV-trained Graph-CNN model improved average AUC to 0.707, with large gains on MUV targets 832, 846, and 852, suggesting DUD-E training coverage was incomplete for those targets.
- The unsupervised pocket autoencoder produced latent pocket embeddings that clustered by SCOP family, and visualization of pocket residues and ligand atoms highlighted interactions corresponding to known co-complex contacts.
Methods
- The framework has two stages: an unsupervised graph autoencoder trained on 965 representative pockets (863 DrugBank-derived high-quality structures representing 262 drugs plus 102 DUD-E pockets) to learn fixed-size pocket fingerprints, followed by a supervised classifier with separate pocket and molecule Graph-CNN modules, an interaction layer, and a softmax binding/non-binding classifier.
- Training used DUD-E (102 targets, on average 224 actives and over 10,000 decoys per target), plus two constructed variants: DUD-E-Pairwise, with negative pockets assigned via PocketFEATURE at a score threshold of -1.9, and DUD-E-CHEMBL assay negatives, using experimentally validated negatives with IC50 > 50 µM and target confidence 9. External validation used 8 MUV targets after filtering for sequence and binding-site dissimilarity to DUD-E.
- Evaluation used four-fold cross-validation split by target for DUD-E, AUC and ROC enrichment (RE) at 0.5%, 1%, 2%, and 5% FPR, MUV AUC/RE, t-SNE visualization of pocket embeddings, binding propensity matrices, dummy-pocket ablation, and saliency-map visualization of pocket residue and ligand atom contributions.
Limitations
- The paper states that DUD-E has limited target number and diversity and provides limited information on ligand-to-target preferences; it also notes that MUV is challenging because it uses experimentally validated negatives, maximally spread actives, and some assays that may not measure direct target-ligand interactions.
- The paper states that Graph-CNN performance dropped on MUV targets 832, 846, and 852, and that the difference between Graph-CNN-DUD-E and Graph-CNN-MUV on these targets suggests interactions learned from DUD-E are still incomplete; it calls for high-quality, large-scale datasets covering both target-ligand and ligand-target binding propensities.
- Evident from the text: the full MUV model was trained for one epoch with no rigorous hyperparameter optimization; the pocket representation relies on FEATURE vectors rather than raw atom distributions; and the first pocket and molecule graph convolution layers were fixed during supervised training.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 13 cited sources checked · 0 supported · 0 flagged
- Findingown data
The model can predict meaningful ligand-target binding profiles.
“we further examined the ability of our model to predict binding propensity of a given compound to different targets and showed that the model can predict meaningful ligand-target binding profiles.”
Quote in the paperSubstantial claim - Findingown data
Graph-autoencoders can learn meaningful fixed-size representations for protein pockets of varying sizes.
“We demonstrate that graph-autoencoders can learn meaningful fixed-size representation for protein pockets of varying sizes”
Quote in the paperSubstantial claim- Rests on an assumption: Protein pockets vary in size and have complex properties.
- Findingown data
The Graph-CNN framework can effectively capture protein-ligand binding interactions without relying on target-ligand co-complexes.
“the Graph-CNN framework can effectively capture protein-ligand binding interactions without relying on target-ligand cocomplexes”
- Also stated in: § Conclusion · boosted
“We further demonstrate that the Graph-CNN framework can effectively capture protein-ligand binding interactions without relying on target-ligand co-complexes.”
Quote in the paperSubstantial claim- Rests on an assumption: Most protein-ligand pairs of interest do not have experimentally solved co-crystal structures.
- Also stated in: § Conclusion · boosted
- Findingown data
The learned pocket embedding in 2D space shows that latent representations reflect biological pocket similarity.
“We visualized the learned pocket embedding in 2D space and show that the latent representations reflect biological pocket similarity.”
Quote in the paperNot a substantial claim - Findingown data
Graph-CNNs achieved better or comparable performance to 3DCNN ligand-scoring, AutoDock Vina, RF-Score, and NNScore on the DUD-E and MUV virtual screening benchmark datasets, without requiring co-crystal structures.
“Across several metrics, Graph-CNNs achieved better or comparable performance to 3DCNN ligand-scoring, AutoDock Vina, RF-Score, and NNScore on common virtual screening benchmark datasets.”
- Also stated in: § I. Introduction · boosted
“We then performed head-to-head comparisons of prediction performance between our Graph-CNNs, 3DCNN ligand-scoring 15 , AutoDock Vina 2 , RF-Score 19 , and NNScore 20 , on the Database of Useful Decoys: Enhanced (DUD-E) 21 and Maximum Unbiased Validation (MUV) 22 dataset and showed that our model achieved better or comparable performances on both datasets without requiring co-crystal structures.”
Quote in the paperSubstantial claim - Also stated in: § I. Introduction · boosted
- Findingown data
Graph-CNN outperformed Vina, RF-Score, and NNScore on the DUD-E dataset.
“the Graph-CNN models outperformed Vina, RF-score, and NNscore models”
Quote in the paperSubstantial claim - Findingown data
Test targets and ligands in fold-0 are clustered reasonably among the targets/ligands in the training set.
“Test targets and ligands in fold-0 (highlighted in yellow) are clustered reasonably among the targets / ligands in the training set.”
Quote in the paperNot a substantial claim - Findingown data
Performance of most MUV target datasets dropped substantially when the true target pockets were absent.
“Performance of most MUV target datasets dropped substantially when the true target pockets are absent.”
Quote in the paperSubstantial claim - Findingown data
Hierarchical clustering on the rows of the binding propensity matrix reveals similarities among the ligand-target binding profiles, dividing the actives into four major clusters: kinases, nuclear receptors, proteases and GPCRs, and other miscellaneous targets.
“Hierarchical clustering on the rows reveals similarities among the ligand-target binding profiles, dividing the actives into four major clusters: (1) kinases (green), (2) nuclear receptors (red), (3) proteases (purple) and GPCRs (blue), and (4) other miscellaneous targets.”
Quote in the paperSubstantial claim - Findingown data
Graph-CNN-MUV achieved an average AUC of 0.707 on the MUV dataset.
“AUC 0.563 0.707 0.518 0.545 0.497 0.430”
Quote in the paperSubstantial claim - Findingown data
For MUV-689 (EPHA4) and compound 2, the identified key pocket residues highly overlap with the key pocket residues observed in the EPHA4-Dasatinib co-complex.
“The pocket importance map highlights residues Met 674, Thr 699, Ala 651, Ile 683, Leu 753, which highly overlap with the key pocket residues observed in the EPHA4-Dasatinib co-complex (Top, PDB: 2Y6O).”
Quote in the paperSubstantial claim - Findingown data
The eight MUV datasets can be divided into four categories corresponding to the four quadrants in the ligand-pocket property space.
“The eight MUV datasets can be divided into four categories, corresponding to the four quadrants in the ligand-pocket property space.”
Quote in the paperNot a substantial claim - Findingown data
Graph-CNNs outperformed ligand-based methods on the hard cases in category I and II.
“On the other hand, Graph-CNNs outperformed ligand-based methods on the hard cases in category I and II.”
Quote in the paperSubstantial claim - Findingown data
Graph-CNN achieved comparable performance with 3DCNN protein-ligand scoring on the DUD-E dataset.
“achieved comparable performance with 3DCNN protein-ligand scoring on the DUD-E dataset”
Quote in the paperSubstantial claim - Findingown data
Graph-CNN achieved the best performance among the structure-based methods across all metrics on the MUV dataset.
“the Graph-CNN models achieved the best performance among the structure-based methods across all metrics.”
Quote in the paperSubstantial claim - Findingown data
Kinases, nuclear receptors, and proteases form distinct clusters in the pocket space.
“Kinases (FAK1, BRAF, MK14, CDK2, IGF1R, CSF1R, EGFR, MK10, VGFR), nuclear receptors (PPARA, PPARD, PPARG, MCR, GCR, PRGR, ESR1, ESR2, THB), proteases (UROK, TRYB1, FA10, FA7 and TRY1) form distinct clusters in the pocket space.”
Quote in the paperNot a substantial claim - Findingown data
Clustering on the columns similarly divides the targets into four major groupings.
“Clustering on the columns similar divides the targets into four major groupings.”
Quote in the paperNot a substantial claim - Findingown data
Similar targets are generally grouped together in the test-target binding propensity matrix.
“Although hierarchical clustering on the columns results in slightly more disperse clusters, similar targets are generally grouped together, and local high-scored blocks are observed between actives of similar targets and their corresponding targets.”
Quote in the paperNot a substantial claim - Findingown data
Graph-CNN achieved an average AUC of 0.563 on the MUV dataset.
“AUC 0.563 0.518 0.545 0.497 0.430”
Quote in the paperSubstantial claim - Findingown data
For HDAC2 and compound 3, the highlighted key residues and ligand functional groups in the importance maps show high similarity to observed interactions in the HDAC2-SAHA co-complex.
“The highlighted key residues and ligand functional groups in the importance maps show high similarity to observed interactions in the HDAC2-SAHA co-complex (Top, PDB: 4LXZ).”
Quote in the paperSubstantial claim - Findingown data
Local high-scored blocks are observed between actives of similar targets and their corresponding targets.
“local high-scored blocks are observed between actives of similar targets and their corresponding targets.”
Quote in the paperNot a substantial claim - Findingown data
Graph-CNN achieved an AUC of 0.886 on the DUD-E dataset.
“AUC 0.886 0.868 0.716 0.622 0.584”
Quote in the paperSubstantial claim - Findingown data
Pockets from the same SCOP family tend to lie closer to each other than to pockets in different SCOP families.
“pockets from the same SCOP family tend to lie closer to each other than to pockets in different SCOP families.”
Quote in the paperSubstantial claim - Findingown data
Graph-CNNs outperformed ligand-based methods on the hard cases in category I and II, where active and negative ligands are mixed in simple molecular descriptor space, regardless of pocket similarities between the MUV target and DUD-E targets.
“On the other hand, Graph-CNNs outperformed ligand-based methods on the hard cases in category I and II, where the active and negative ligands are mixed in simple molecular descriptor space, regardless of the pocket similarities between the MUV target and DUD-E targets.”
Quote in the paperSubstantial claim - Findingreasoning
Ligand-based methods outperformed structure-based methods on datasets in category III (targets 852, 846, 832) where actives and negatives are well-separated in chemical space.
“As expected, ligand-based methods outperformed structure-based methods on datasets in category III: target 852, target 846, target 832, where actives and negatives are well-separated in the chemical space.”
Quote in the paperSubstantial claim - Findingown data
For ESR1 and compound 4, the highlighted key residues and ligand functional groups agree with the interactions observed between ESR1 and THC.
“The ligand importance map highlights the two hydroxyl groups and the polycyclic ring region, which agrees with the interactions observed between ESR1 and THC (Top, PDB: 1L2I).”
Quote in the paperSubstantial claim - Findingown data
Graph-autoencoders can learn meaningful fixed-size representation for protein pockets of varying sizes that reflects protein family similarities.
“Our results show that graph-autoencoders can learn meaningful fixed-size representation for protein pockets of varying sizes that reflects protein family similarities.”
Quote in the paperSubstantial claim - Findingown data
Targets 832, 852, and 846 showed improved performance when only ligand information is provided.
“Interestingly, target 832, 852 and 846 showed improved performance when only ligand information is provided.”
Quote in the paperNot a substantial claim - Findingown data
The pocket importance map shows that the decision depends on residues Met 674, Thr 699, Ala 651, Ile 683, Leu 753, which highly overlap with the key pocket residues observed in the EPHA4-Dasatinib cocomplex (PDB: 2Y6O).
“The pocket importance map shows that the decision depends on residues Met 674, Thr 699, Ala 651, Ile 683, Leu 753, which highly overlap with the key pocket residues observed in the EPHA4-Dasatinib cocomplex (PDB: 2Y6O).”
Quote in the paperNot a substantial claim - Findingown data
Ligand-based methods outperformed structure-based methods on MUV datasets in category III: targets 852, 846, and 832.
“Ligand-based methods outperformed structure-based methods on datasets in category III: target 852, target 846, target 832.”
Quote in the paperNot a substantial claim - Findingown data
The Graph-CNN correctly classified the MUV-689 (EPHA4) and compound 2 pocket-ligand pair as positive.
“The Graph-CNN correctly classify the pocket-ligand pair as positive.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Since the fine-tune stage training is end-to-end, driven by supervised labels, the model will automatically extract task-specific features characterizing interactions between target and molecules.
“Furthermore, since the fine-tune stage training is end-to-end, driven by supervised labels, the model will automatically extract task-specific features characterizing interactions between target and molecules.”
Quote in the paperSubstantial claim - Interpretationreasoning
Since features of pockets and molecules are learned through two Graph-CNN models in parallel, the model does not require protein-ligand co-complex as input.
“Since features of pockets and molecules are learned through two Graph-CNN models in parallel, the model does not require proteinligand co-complex as input.”
Quote in the paperSubstantial claim- Rests on an assumption: Most protein-ligand pairs of interest do not have experimentally solved co-crystal structures.
- Premisecitation
Physic-based methods such as docking can be sensitive to structural error or pocket conformational changes.
“Albeit powerful, due to their heavy dependency on atomic distances to evaluate scoring functions, these methods can be sensitive to structural error or pocket conformational changes 3 .”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] source
Not checked in the free run.
- Premisereasoning
Since computational decoys are chosen to be dissimilar to actives, the DUD-E benchmark excludes challenging cases where actives and negatives are similar.
“Since the computational decoys are chosen to be dissimilar to actives, the benchmark excludes challenging cases where actives and negatives are similar.”
Quote in the paperSubstantial claim - Interpretationreasoning
The unsupervised framework allows exploiting available protein structures that have known binding sites but no sufficient binding data to learn general-purpose, fixed-sized protein pocket descriptors.
“The unsupervised framework allows us to exploit available protein structures that have known binding sites but no sufficient binding data to learn general-purposed, fixed-sized protein pocket descriptors.”
Quote in the paperSubstantial claim - Premisecitation
The constructed pocket set represents a comprehensive collection of druggable binding sites.
“The constructed pocket set represents a comprehensive collection of druggable binding sites.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Liu et al. 4
Not checked in the free run.
- Premisecitation
Computational decoys in DUD-E are chosen to be physically similar but topologically dissimilar to the actives.
“Computational decoys are chosen such that they are physically similar but topologically dissimilar to the actives.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] source
Not checked in the free run.
- Premisenone given
The original DUD-E dataset lacks experimentally validated negatives.
“Another limitation of the original DUD-E dataset is the lack of experimentally validated negatives.”
Quote in the paperSubstantial claim - Interpretationown data
The networks recognize meaningful interactions between protein pockets and ligands, as shown by visualization of individual contributions of pocket residues and ligand atoms to classification decisions.
“Visualization of key pocket residues and ligand atoms contributing to the classification decisions confirms that our networks recognize meaningful interactions between pockets and ligands.”
- Also stated in: § I. Introduction · plain
“Finally, we visualized individual contributions of each pocket residue and ligand atom to the classification decision and showed that our networks recognize meaningful interactions between protein pockets and ligands.”
Quote in the paperSubstantial claim - Also stated in: § I. Introduction · plain
- Premisecitation
Both actives and negatives in the MUV dataset are experimentally validated based on PubChem bioactivity data.
“Both actives and negatives are experimentally validated based on PubChem 43 bioactivity data.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites PubChem 43
Not checked in the free run.
- Premisecitation
3DCNNs can extract meaningful features of amino acid microenvironments directly from raw atom distribution.
“We have previously shown that 3DCNNs can extract meaningful features of amino acid microenvironments directly from raw atom distribution 12 .”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] source
Not checked in the free run.
- Interpretationown data
The graph autoencoder learned meaningful pocket embeddings that reflect known pocket similarities.
“The graph autoencoder learned meaningful pocket embeddings that reflect known pocket similarities.”
Quote in the paperSubstantial claim - Interpretationown data
Graph-CNNs and AP thrive at different scenarios.
“Further analysis on the ligand and pocket properties of each MUV dataset reveals that Graph-CNNs and AP thrives at different scenarios.”
Quote in the paperSubstantial claim - Interpretationown data
The learned ligand-target binding relationship is generalizable to unseen targets.
“demonstrating that the learned ligand-target binding relationship is generalizable to unseen targets.”
Quote in the paperSubstantial claim - Interpretationown data
The low performance on targets 852, 846, and 832 may be due to the limited coverage of interactions in the DUD-E dataset.
“This suggests that the low performance may be due to the limited coverage of interactions in the DUD-E dataset”
Quote in the paperSubstantial claim - Interpretationreasoning
These design choices make MUV particularly challenging for structure-based methods.
“These design choices make MUV particularly challenging for structure-based methods.”
Quote in the paperSubstantial claim- Rests on an assumption: The MUV dataset does not use computational decoys.
- Rests on an assumption: The actives in the MUV dataset are selected to be maximally spread based on simple descriptors and embedded in decoys.
- Rests on an assumption: Both chemical-based and cell-based assays are used to construct the MUV dataset.
- Interpretationreasoning
Training on datasets with limited target diversity can result in models that perform well on prioritizing ligands for targets similar to training set but poorly on ranking a ligand's true target over random targets or on interactions beyond training data.
“Training on such dataset can result in models that perform well on prioritizing ligands for targets that are similar to those in the training set while perform badly on ranking a ligand's true target over random targets or perform less than ideal on target-ligand interactions beyond the relationship inherent in the training data.”
Quote in the paperSubstantial claim- Rests on an assumption: Virtual screening datasets often provide information about ligand binding propensity to given targets but have limited information on target preferences of given ligands.
- Rests on an assumption: Current benchmark datasets often include limited number of targets, which only cover a subset of potential target space.
- Rests on an assumption: To learn a generalizable model of protein-ligand binding, the quality of the training dataset is crucial.
- Interpretationown data
The Graph-CNN recognizes meaningful target-ligand interactions to make predictions.
“Visualization of individual contributions of each pocket residue and ligand atom also confirmed that our Graph-CNNs recognize meaningful interactions between protein pockets and ligands.”
- Also stated in: § Conclusion · hedged
“The high correspondence of the predicted and observed key residues and ligand atoms in the two target-ligand pairs suggests that the Graph-CNN is able to recognize meaningful target-ligand interactions to make predictions.”
- Also stated in: § Conclusion · hedged
“The high correspondence between the predicted and observed key residues and functional groups suggests that the network was using meaningful interactions to make predictions.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · hedged
- Interpretationown data
The significant difference between performance of Graph-CNN-DUD-E and Graph-CNN-MUV models on MUV targets 832, 852 and 846 suggests that the interactions learned from the DUD-E dataset are still incomplete.
“However, the significant difference between performance of Graph-CNN-DUD-E and Graph-CNN-MUV models on MUV targets 832, 852 and 846 suggests that the interactions learned from the DUD-E dataset are still incomplete.”
Quote in the paperSubstantial claim - Premisecitation
The polycyclic ring interacts with the hydrophobic residues including Ala 350, Leu 387, Leu 384, Leu 525, Leu 391, Met 388 and Leu 346.
“The polycyclic ring interacts with the hydrophobic residues including Ala 350, Leu 387, Leu 384, Leu 525, Leu 391, Met 388 and Leu 346 49 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] source
Not checked in the free run.
- May combine two claims. 18
- The quote only partly states this claim. 3
- Classified as probably not a substantial claim. 17
May combine two claims.
Findingown dataAcross several metrics, Graph-CNNs achieved better or comparable performance to 3DCNN ligand-scoring, AutoDock Vina, RF-Score, and NNScore on the DUD-E and MUV benchmark, and showed complementary advantages to ligand-based methods.
“Across several metrics, Graph-CNNs achieved better or comparable performance to 3DCNN ligand-scoring, AutoDock Vina, RF-Score, and NNScore on the DUD-E and MUV benchmark, and showed complementary advantages to ligand-based methods.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLocal high-scored blocks form at the intersections of the corresponding row and column clusters, showing that ligands are predicted to have stronger interactions with targets that are similar to its primary target compared to unrelated targets and vice versa.
“Local high-scored blocks form at the intersections of the corresponding row and column clusters, showing that ligands are predicted to have stronger interactions with targets that are similar to its primary target compared to unrelated targets and vice versa.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe Graph-CNN-MUV models achieve significant improvements over Graph-CNN-DUD-E on targets 832, 846, and 852, achieving AUC scores comparable to AP.
“The Graph-CNN-MUV models achieve significant improvements over Graph-CNN-DUDE on targets 832, 846, and 852, achieving AUC scores comparable to AP.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGraph-CNN achieved the best performance among the 5 methods for targets 859, 692, 689, and 466, whereas AP achieved the best performance for targets 548, 832, 852, and 846.
“Graph-CNN achieved the best performance among the 5 methods for target 859, 692, 689, 466 whereas AP achieved the best performance for target 548, 832, 852, 846.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGraph-CNN-MUV models achieve significant improvements on targets 852, 846, and 832, achieving AUC scores comparable to AP.
“the Graph-CNN-MUV models achieve significant improvements on the three targets, achieving AUC scores comparable to AP.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGraph-CNN attained AUC greater than 0.6 for 5 out of 8 MUV targets, while Vina, 3DCNN, RF-Score, and NNScore have no more than two targets achieving an AUC greater than 0.6.
“While Vina, 3DCNN, RF-score, and NNscore have no more than two targets achieving an AUC greater than 0.6, the Graph-CNN models attain AUC greater than 0.6 for 5 out of 8 targets.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe model can generate meaningful ligand-target binding profiles and achieved better generalizability on the MUV dataset compared to other machine-learning and deep learning structure-based methods.
“We show that our model can generate meaningful ligand-target binding profiles and achieved better generalizability on the MUV dataset compared to other machine-learning and deeplearning structure-based methods.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataFor SRC (PDB: 3EL8) and compound 1, the identified key residues and atoms from the importance maps highly correspond to the observed interacting residues and ligand atoms in the co-crystalized complex.
“The identified key residues and atoms highly correspond to the observed interacting residues and ligand atoms in the co-crystalized complex of SRC and pyrazolopyrimidine 5 (Top, PDB: 3EL8).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll methods, except Vina, performed well on category IV (target 548) where ligands are separated and pocket similarity is relatively high.
“All methods, except Vina, performed well on category IV (target 548) where ligands are separated and the pocket similarity is relatively high.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisereasoning3DCNN methods for protein-ligand interaction prediction require a data-preprocessing step that artificially docks query ligands into their targets, and this cross-docking step can introduce significant noise.
“However, since most protein-ligand pairs of interests do not have experimentally solved co-crystal structures, to generate protein-ligand co-complex for training and testing, these methods require a data-preprocessing step that artificially docks query ligands into their targets.This cross-docking step can introduce significant noises, stemming from cross-docking ligands into noncognate receptors.”
Quote in the paperSubstantial claim- Rests on an assumption: Most protein-ligand pairs of interest do not have experimentally solved co-crystal structures.
May combine two claims.
PremisecitationThe DUD-E dataset consists of 102 targets across different protein families, with on average 224 actives and over 10,000 decoys per target.
“The DUD-E dataset consists of 102 targets across different protein families.On average, each target has 224 actives and over 10,000 decoys.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] source
Not checked in the free run.
May combine two claims.
PremisereasoningThe DUD-E dataset has limited number and diversity of protein targets, so learned features may be biased towards certain subsets of targets.
“which has limited number and diversity of protein targets.”
- Also stated in: § I. Introduction · hedged
“The learned features may therefore be biased towards certain subsets of targets.”
Quote in the paperSubstantial claim- Also stated in: § I. Introduction · hedged
May combine two claims.
PremisereasoningThe DUD-E dataset emphasizes assessing binding preferences of a given target to different ligands but does not provide much information regarding preferences of a given ligand to different targets.
“Because the DUD-E dataset was designed for virtual screening tasks, it emphasizes on assessing binding preferences of a given target to different ligands.However, it does not provide much information regarding preferences of a given ligand to different targets.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenViewing protein pockets as graphs of residue nodes allows pockets of arbitrary size to be represented and imposes relatively weak geometry constraints.
“Viewing protein pockets as graphs of residue nodes allows pockets of arbitrary size to be represented and imposes relatively weak geometry constraints.”
Quote in the paperNot a substantial claim- Rests on an assumption: Protein pockets vary in size and have complex properties.
The quote only partly states this claim.
Study design and conductcitationThe final MUV external validation set comprises eight targets selected to have no more than 80% global sequence identity and no significant binding site structural similarity to any DUD-E target.
“Following procedures described in Ragoza et al. 15 , we selected MUV targets that have no more than 80% global sequence identity to any DUD-E target.Furthermore, targets with significant binding site structural similarity to any of the DUD-E target binding site were removed.Finally, only unique targets with available crystal structure of the pocket site were included.The above procedure results in”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ragoza et al. 15
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe Graph-CNN framework can be layered on top of 3DCNNs that characterize local pocket residue environments to enable an end-to-end framework that learns biochemical features directly from raw crystal structures.
“The proposed Graph-CNN framework can be layered on top of 3DCNNs that characterize local pocket residue environments to further enable an end-toend framework that learns biochemical features directly from raw crystal structures.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. The quote only partly states this claim.
Study design and conductnone givenThe folds in the four-fold cross-validation were split between targets, with all ligands of the same target belonging to the same fold.
“The folds are split between targets, where all ligands of the same target belong to the same fold.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenEach node in the interaction hidden layer represents a favorable or non-favorable interaction type between the target and ligand.
“Each node in the interaction hidden layer represents a favorable or non-favorable interaction type between the target and ligand.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenWithin each training fold, three targets were randomly selected as validation dataset for hyperparameter tuning.
“Within each training fold, we randomly selected three targets as our validation dataset, and choose our model hyper-parameters based on the validation performances.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAP is the best performing method reported in a large-scale virtual screening study of ligand-based methods conducted by Riniker et al.
“AP is the best performing method reported in a large-scale virtual screening study of ligand-based methods conducted by Riniker et al. 7”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Riniker et al. 7
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataThe study used a four-fold cross-validation strategy to train and evaluate Graph-CNNs on the DUD-E dataset.
“We adopt a four-fold cross-validation strategy to train and evaluate our Graph-CNNs on the DUD-E -Pairwise interaction dataset (section 2.1.2(A)).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenMultiple graph autoencoder layers can be stacked and trained greedily, allowing features of different complexity to be integrated through a hierarchical manner.
“Multiple graph autoencoder layers can be stacked and trained greedily, allowing features of different complexity to be integrated through a hierarchical manner.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe pyrimidine ring makes contact with Ile 627.
“The pyrimidine ring makes contact with Ile 627.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningSuch a design can simultaneously allow detailed characterization at the local amino acid environment level and global flexibility at the pocket level.
“Such design can simultaneously allow detailed characterization at the local amino acid environment level and global flexibility at the pocket level.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenNo two folds had targets with greater than 75% global sequence identity.
“we ensured that no any two folds have targets with greater than 75% global sequence identity.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningOur ligand interaction map highlights the benzene ring, the nearby oxygen, and the polycyclic ring in compound 2 as the key features, which may play the roles of the pyrimidine ring, the amino-thiazole ring, and the 2-chloro-6-methyl phenyl group, respectively.
“Our ligand interaction map highlights the benzene ring, the nearby oxygen, and the polycyclic ring in compound 2 as the key features, which may play the roles of the pyrimidine ring, the amino-thiazole ring, and the 2-chloro-6methyl phenyl group, respectively.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningFor the MUV cross-validation, the folds were split between targets.
“Similar to the training of the DUD-E models, the folds are split between targets.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThe learned pocket representation can enable efficient pocket similarity search, pocket classification, and serve as input for downstream machine learning algorithms.
“Such representation has the potential to enable efficient pocket similarity search, pocket classification, and can serve as input for downstream machine learning algorithms.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe 2-chloro-6-methyl phenyl group of dasatinib occupies the hydrophobic pocket and makes van der Waals contacts with Met 674, Ile 683, Ile 697 and Thr 699.
“The 2-chloro-6-methyl phenyl group of dasatinib occupies the hydrophobic pocket and makes van der Waals contacts with Met 674, Ile 683, Ile 697 and Thr 699.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe amino-thiazole ring has van der Waals contacts with Leu 753 and Ala 651, and also forms hydrogen bonds with Met 702.
“The amino-thiazole ring has van der Waals contacts with Leu 753 and Ala 651, and also forms hydrogen bonds with Met 702.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe supervised model was trained for a full epoch and no rigorous attempt was made to optimize the hyperparameters.
“The supervised model was trained for a full epoch and no rigorous attempt was made to optimize the hyperparameters.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe amide group forms hydrogen bond with Thr 699.
“The amide group forms hydrogen bond with Thr 699.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] source
Not checked in the free run.
The paper relies on this without support.
Protein pockets vary in size and have complex properties.
“Protein pockets are of varying sizes and with complex properties.”
The paper relies on this without support.
It is challenging to define protein pocket similarity or to embed a protein pocket as a fixed-size vector for downstream machine learning tasks without emphasizing certain aspects of pocket properties while ignoring others.
“It is challenging to define protein pocket similarity or to embed protein pocket as a fixed-size vector for downstream machine learning tasks without emphasizing certain aspects of pocket properties while ignoring others.”
The paper relies on this without support.
Biochemical interactions start between atoms and can be aggregated over space to form complex interactions.
“Biochemical interactions start between atoms, and can be similarly aggregated over space to form complex interactions.”
The paper relies on this without support.
Most protein-ligand pairs of interest do not have experimentally solved co-crystal structures.
“However, since most protein-ligand pairs of interests do not have experimentally solved co-crystal structures”
The paper relies on this without support.
Target-ligand binding interactions are promiscuous.
“Target-ligand binding interactions are known to be promiscuous.”
The paper relies on this without support.
Ligand-based methods achieve better performances than structure-based methods on the MUV dataset.
“ligand-based methods are known to achieve better performances than structure-based methods on the MUV dataset”
The paper relies on this without support.
The MUV dataset does not use computational decoys.
“Unlike DUD-E, the MUV dataset does not use computational decoys.”
The paper relies on this without support.
The actives in the MUV dataset are selected to be maximally spread based on simple descriptors and embedded in decoys.
“the actives are selected to be maximally spread based on simple descriptors and embedded in decoys.”
The paper relies on this without support.
Both chemical-based and cell-based assays are used to construct the MUV dataset.
“both chemical-based and cell-based assays are used to construct dataset”
The paper relies on this without support.
Virtual screening datasets often provide information about ligand binding propensity to given targets but have limited information on target preferences of given ligands.
“Virtual screening dataset often provide information about ligand binding propensity to given targets but have limited information on target preferences of given ligands.”
The paper relies on this without support.
Current benchmark datasets often include limited number of targets, which only cover a subset of potential target space.
“Moreover, current benchmark datasets often include limited number of targets, which only cover a subset of potential target space.”
The paper relies on this without support.
To learn a generalizable model of protein-ligand binding, the quality of the training dataset is crucial.
“To learn a generalizable model of protein-ligand binding, the quality of the training dataset is crucial.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rigorous analyses suggest that GCNNs do not improve predictive performance compared to 'classical QSAR' fingerprints.
“Rigorous analyses suggest that GCNNs do not improve predictive performance compared to 'classical QSAR' fingerprints (92).”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [92]
In “External Dataset Validation: MUV” (page unavailable), the paper reports that Graph-CNN had the best performance among five methods on four of eight targets, while the ligand-based AP method led on the other four. Its analysis says Graph-CNNs outperformed ligand-based methods on the harder cases, rather than finding that they do not improve predictive performance over fingerprint-based methods. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredGCNNs have been used to model drug combinations, drug-target interactions, and multiple property predictions.
“GCNNs have been used to model drug combinations (90), drug-target interactions (91), and multiple property predictions (92).”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting counts for the DUD-E pocket visualization
MinorThe methods report 393 pockets from 47 SCOP families for this visualization, while the results report 401 pockets from 48 families.
“We additionally visualize DUDE targets and their corresponding SCOP family members, which comprises 393 pockets from 47 SCOP families.”
“Figure 3b and 3c shows the distribution of the DUDE targets and the corresponding SCOP family members (401 pockets from the 48 SCOP families).”
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126 · see citing works
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196 · see citing works
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412 · see citing works
(2008) · Journal of Machine Learning Research · Cited by 33,051 · see citing works
Silhouettes: A graphical aid to the interpretation and validation of cluster analysis
Rousseeuw, P. J. (1987) · Journal of Computational and Applied Mathematics · doi:10.1016/0377-0427(87)90125-7 · Cited by 21,392 · see citing works
Hierarchical Grouping to Optimize an Objective Function
Ward, J. H. (1963) · Journal of the American Statistical Association · doi:10.1080/01621459.1963.10500845 · Cited by 21,341 · see citing works
Extended-Connectivity Fingerprints
Rogers, D. O. W., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,597 · see citing works
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436 · see citing works
Extracting and composing robust features with denoising autoencoders
Vincent, P., Larochelle, H., Bengio, Y., & Manzagol, P.-A. (2008) · Proceedings of the 25th international conference on Machine learning - ICML '08 · doi:10.1145/1390156.1390294 · Cited by 7,436 · see citing works
Murzin, A. G., Brenner, S. E., Hubbard, T., & Chothia, C. (1995) · Journal of Molecular Biology · doi:10.1016/s0022-2836(05)80134-2 · Cited by 6,412 · see citing works
PubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436 · see citing works
Deep Inside Convolutional Networks: Visualising Image Classification Models and Saliency Maps
Simonyan, K., Vedaldi, A., & Zisserman, A. (2013) · arXiv · doi:10.48550/arxiv.1312.6034 · Cited by 5,370 · see citing works
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · see citing works
Python for scientific computing
Oliphant, T. E. (2007) · Computing in Science & Engineering · doi:10.1109/mcse.2007.58 · Cited by 3,303 · see citing works
Hierarchical Grouping to Optimize an Objective Function
Ward, J. H. (1963) · Journal of the American Statistical Association · doi:10.2307/2282967 · Cited by 3,294 · see citing works
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.
Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412 · see citing works
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402 · see citing works
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,832 · see citing works
DeepDTA: deep drug–target binding affinity prediction
Öztürk, H., Özgür, A., & Özkırımlı, E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty593 · Cited by 1,728 · see citing works
Morgan, H. L. (1965) · Journal of Chemical Documentation · doi:10.1021/c160017a018 · Cited by 1,716 · see citing works
Molecular graph convolutions: moving beyond fingerprints
Kearnes, S., McCloskey, K., Berndl, M., Pande, V., & Riley, P. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9938-8 · Cited by 1,631 · see citing works
Bridle, J. S. (1990) · Springer eBooks · doi:10.1007/978-3-642-76153-9_28 · Cited by 1,278 · see citing works
Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise
Koes, D. R., Baumgartner, M. P., & Camacho, C. J. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300604z · Cited by 1,150 · see citing works
Atom pairs as molecular features in structure-activity studies: definition and applications
Carhart, R. E., Smith, D. H., & Venkataraghavan, R. (1985) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00046a002 · Cited by 1,120 · see citing works
Ballester, P. J., & Mitchell, J. B. O. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq112 · Cited by 988 · see citing works
Protein–Ligand Scoring with Convolutional Neural Networks
Ragoza, M., Hochuli, J. E., Idrobo, E., Sunseri, J., & Koes, D. R. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00740 · Cited by 835 · see citing works
Implications of protein flexibility for drug discovery
Teague, S. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1129 · Cited by 755 · see citing works
Wallach, I., Dzamba, M., & Heifets, A. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1510.02855 · Cited by 698 · see citing works
Tsubaki, M., Tomii, K., & Sese, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty535 · Cited by 688 · see citing works
Karimi, M., Wu, D. J., Wang, Z., & Shen, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz111 · Cited by 536 · see citing works
He, T., Heidemeyer, M., Ban, F., Cherkasov, A. R., & Ester, M. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0209-z · Cited by 516 · see citing works
Lauffer, B. E. L., Mintzer, R., Fong, R., Mukund, S., Tam, C., Zilberleyb, I., Flicke, B., Ritscher, A., Fedorowicz, G., Vallero, R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.490706 · Cited by 429 · see citing works
Maximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data
Rohrer, S. G., & Baumann, K. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci8002649 · Cited by 403 · see citing works
Open-source platform to benchmark fingerprints for ligand-based virtual screening
Riniker, S., & Landrum, G. A. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-26 · Cited by 363 · see citing works
The mechanism of action of S-adenosylhomocysteinase.
Palmer, J. L., & Abeles, R. H. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34190-x · Cited by 357 · see citing works
Shiau, A. K., Barstad, D., Radek, J. T., Meyers, M. J., Nettles, K. W., Katzenellenbogen, B. S., Katzenellenbogen, J. A., Agard, D. A., & Greene, G. L. (2002) · Nature Structural Biology · doi:10.1038/nsb787 · Cited by 357 · see citing works
Recommendations for evaluation of computational methods
Jain, A. N., & Nicholls, A. O. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9196-5 · Cited by 350 · see citing works
Konc, J., & Janežič, D. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq100 · Cited by 275 · see citing works
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides
Bressi, J. C., Jennings, A. J., Skene, R., Wu, Y., Melkus, R., Jong, R. D., O’Connell, S., Grimshaw, C. E., Navre, M., & Gangloff, A. R. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.091 · Cited by 261 · see citing works
Durrant, J. D., & McCammon, J. A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100244v · Cited by 258 · see citing works
What do we know and when do we know it?
Nicholls, A. O. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9170-2 · Cited by 203 · see citing works
3D deep convolutional neural networks for amino acid environment similarity analysis
Torng, W., & Altman, R. B. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1702-0 · Cited by 142 · see citing works
Self-citationCharacterizing the microenvironment surrounding protein sites
Bagley, S. C., & Altman, R. B. (1995) · Protein Science · doi:10.1002/pro.5560040404 · Cited by 134 · see citing works
Self-citationCichońska, A., Ravikumar, B., Parri, E., Timonen, S., Pahikkala, T., Airola, A., Wennerberg, K., Rousu, J., & Aittokallio, T. A. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005678 · Cited by 122 · see citing works
Kim, S., Wu, J. Y., Birzin, E. T., Frisch, K., CHAN, W. W.-S., Pai, L.-Y., Yang, Y. T., Mosley, R. T., Fitzgerald, P. M. D., Sharma, N., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm034243o · Cited by 102 · see citing works
Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation
Dar, A. C., Lopez, M. S., & Shokat, K. M. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.09.007 · Cited by 89 · see citing works
High precision protein functional site detection using 3D convolutional neural networks
Torng, W., & Altman, R. B. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty813 · Cited by 69 · see citing works
Self-citationLiu, T., & Altman, R. B. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002326 · Cited by 64 · see citing works
Self-citationAnderson, W. F., & Steitz, T. A. (1975) · Journal of Molecular Biology · doi:10.1016/0022-2836(75)90227-2 · Cited by 55 · see citing works
Liu, T., & Altman, R. B. (2014) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.66 · Cited by 39 · see citing works
Self-citationStructural Learning of Proteins Using Graph Convolutional Neural Networks
Zamora-Resendiz, R., & Crivelli, S. (2019) · doi:10.1101/610444 · Cited by 37 · see citing works
Liu, T., & Altman, R. B. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00030 · Cited by 35 · see citing works
Self-citationComputational analysis of kinase inhibitor selectivity using structural knowledge
Lo, Y., Liu, T., Morrissey, K. M., Kakiuchi-Kiyota, S., Johnson, A. R., Broccatelli, F., Zhong, Y., Joshi, A., & Altman, R. B. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty582 · Cited by 34 · see citing works
Self-citationLo, Y., Cormier, O., Liu, T., Nettles, K. W., Katzenellenbogen, J. A., Stearns, T., & Altman, R. B. (2019) · Nature Communications · doi:10.1038/s41467-019-08965-w · Cited by 27 · see citing works
Self-citationCrystal structure of the EphA4 protein tyrosine kinase domain in the apo- and dasatinib-bound state
Farenc, C., Celie, P. H. N., Tensen, C. P., de Esch, I. J. P., & Siegal, G. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.10.028 · Cited by 22 · see citing works
ProtChemSI: a network of protein-chemical structural interactions
Kalinina, O. V., Wichmann, O., Apic, G., & Russell, R. B. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1049 · Cited by 14 · see citing works
End-to-End Learning Based Compound Activity Prediction Using Binding Pocket Information
Tanebe, T., & Ishida, T. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-26969-2_21 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- Krizhevsky A., 2012, In Adv. Neural Inf. Process. Syst., 2012, 1097
- Wallach I., 2015, arXiv, arXiv:1510.0285
- Duvenaud D. K., 2015, In Adv. Neural Inf. Process. Syst., 2015, 2224
- Fout A., 2017, In Adv. Neural Inf. Process. Syst., 2017, 6530
- Yoon S., BMC Bioinformatics, 2007, 8, S10
- Glorot X., 2011, In Proceedings of the fourteenth international conference on artificial intelligence and statistics, 2011, 315
- Tieleman T., 2012, COURSERA: Neural networks for machine learning, 4, 26
- Maaten L. v. d., 2008, Journal of machine learning research, 9, 2579
Cited by
Sorted by citations
GraphDTA: predicting drug–target binding affinity with graph neural networks
Nguyen, T., Le, H., Quinn, T. P., Nguyen, T., Le, T. D., & Venkatesh, S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa921 · Cited by 1,270 · see citing works
Deep neural networks for the evaluation and design of photonic devices
Jiang, J., Chen, M., & Fan, J. A. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-00260-1 · Cited by 601 · see citing works
The Art and Science of Molecular Docking
Paggi, J. M., Pandit, A., & Dror, R. O. (2024) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-030222-120000 · Cited by 511 · see citing works
Bhatti, U. A., Tang, H., Wu, G., Marjan, S., & Hussain, A. (2023) · International Journal of Intelligent Systems · doi:10.1155/2023/8342104 · Cited by 481 · see citing works
Graph Neural Networks and Their Current Applications in Bioinformatics
Zhang, X., Li, L., Liu, L., & Tang, M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.690049 · Cited by 413 · see citing works
Deep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul-Ella, H., Elshaier, Y., Gomaa, M. M., & Hassanien, A. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 328 · see citing works
Machine-learning methods for ligand–protein molecular docking
Crampon, K., Giorkallos, A., Deldossi, M., Baud, S., & Steffenel, L. A. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.007 · Cited by 406 · see citing works
Lim, J., Ryu, S., Park, K., Choe, Y. J., Ham, J., & Kim, W. Y. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00387 · Cited by 403 · see citing works
Geometric deep learning on molecular representations
Atz, K., Grisoni, F., & Schneider, G. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00418-8 · Cited by 387 · see citing works
Yang, Z., Zhong, W., Zhao, L., & Chen, C. Y. (2022) · Chemical Science · doi:10.1039/d1sc05180f · Cited by 354 · see citing works
Utilizing graph machine learning within drug discovery and development
Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313 · see citing works
Predicting drug–protein interaction using quasi-visual question answering system
Zheng, S., Li, Y., Chen, S., Xu, J., & Yang, Y. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-0152-y · Cited by 310 · see citing works
MolGpka: A Web Server for Small Molecule p K a Prediction Using a Graph-Convolutional Neural Network
Pan, X., Wang, H., Li, C., Zhang, J. Z. H., & Ji, C. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00075 · Cited by 283 · see citing works
Zhao, Q., Zhao, H., Zheng, K., & Wang, J. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab715 · Cited by 280 · see citing works
Biological network analysis with deep learning
Muzio, G., O’Bray, L., & Borgwardt, K. M. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa257 · Cited by 267 · see citing works
Jiang, D., Hsieh, C., Wu, Z., Kang, Y., Wang, J., Wang, E., Liao, B., Shen, C., Xu, L., Wu, J. F., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01830 · Cited by 260 · see citing works
The transformational role of GPU computing and deep learning in drug discovery
Pandey, M., Fernandez, M., Gentile, F., Isayev, O., Tropsha, A., Stern, A. C., & Cherkasov, A. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00463-x · Cited by 255 · see citing works
MONN: A Multi-objective Neural Network for Predicting Compound-Protein Interactions and Affinities
Li, S., Wan, F., Shu, H., Jiang, T., Zhao, D. Y., & Zeng, J. (2020) · Cell Systems · doi:10.1016/j.cels.2020.03.002 · Cited by 245 · see citing works
Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
Arshadi, A. K., Webb, J., Salem, M., Cruz, E., Calad-Thomson, S., Ghadirian, N., Collins, J., Diez‐Cecilia, E., Kelly, B., Goodarzi, H., et al. (2020) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2020.00065 · Cited by 245 · see citing works
Artificial Intelligence for Drug Discovery: Are We There Yet?
Hasselgren, C., & Oprea, T. I. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040323-040828 · Cited by 236 · see citing works
Deep Learning in Protein Structural Modeling and Design
Gao, W., Mahajan, S. P., Sulam, J., & Gray, J. J. (2020) · Patterns · doi:10.1016/j.patter.2020.100142 · Cited by 227 · see citing works
Deep Learning in Virtual Screening: Recent Applications and Developments
Kimber, T. B., Chen, Y., & Volkamer, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094435 · Cited by 213 · see citing works
A review on machine learning algorithms for the ionic liquid chemical space
Koutsoukos, S., Philippi, F., Malaret, F., & Welton, T. (2021) · Chemical Science · doi:10.1039/d1sc01000j · Cited by 200 · see citing works
Moon, S., Zhung, W., Yang, S., Lim, J., & Kim, W. Y. (2022) · Chemical Science · doi:10.1039/d1sc06946b · Cited by 193 · see citing works
Graph neural networks for automated de novo drug design
Xiong, J., Xiong, Z., Chen, K., Jiang, H., & Zheng, M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.011 · Cited by 192 · see citing works
DeepRank-GNN: a graph neural network framework to learn patterns in protein–protein interfaces
Réau, M., Renaud, N., Xue, L. C., & Bonvin, A. M. J. J. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btac759 · Cited by 190 · see citing works
Graph neural network approaches for drug-target interactions
Zhang, Z., Chen, L., Zhong, F., Wang, D., Jiang, J., Zhang, S., Jiang, H., Zheng, M., & Li, X. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.102327 · Cited by 184 · see citing works
Wu, H., Liu, J., Jiang, T., Zou, Q., Qi, S., Cui, Z., Tiwari, P., & Ding, Y. (2023) · Neural Networks · doi:10.1016/j.neunet.2023.11.018 · Cited by 183 · see citing works
Volkov, M., Turk, J.-A., Drizard, N., Martin, N., Hoffmann, B., Gaston‐Mathé, Y., & Rognan, D. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00487 · Cited by 182 · see citing works
Structure-based drug design with geometric deep learning
Isert, C., Atz, K., & Schneider, G. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102548 · Cited by 182 · see citing works
Xia, Y., Xia, C., Pan, X., & Shen, H. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab044 · Cited by 179 · see citing works
Shen, C., Zhang, X., Deng, Y., Gao, J., Wang, D., Xu, L., Pan, P., Hou, T., & Kang, Y. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00991 · Cited by 179 · see citing works
Joung, J. F., Han, M., Hwang, J., Jeong, M., Choi, D. H., & Park, S. (2021) · JACS Au · doi:10.1021/jacsau.1c00035 · Cited by 174 · see citing works
Multimodal learning with graphs
Ektefaie, Y., Dasoulas, G., Noori, A., Farhat, M., & Zitnik, M. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00624-6 · Cited by 166 · see citing works
Xuan, P., Pan, S., Zhang, T., Liu, Y., & Sun, H. (2019) · Cells · doi:10.3390/cells8091012 · Cited by 159 · see citing works
Comprehensive Survey of Recent Drug Discovery Using Deep Learning
Kim, J., Park, S., Min, D., & Kim, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189983 · Cited by 141 · see citing works
Chen, M., Zhang, Z., Wang, T., Backes, M., Humbert, M., & Zhang, Y. (2022) · Proceedings of the 2022 ACM SIGSAC Conference on Computer and Communications Security · doi:10.1145/3548606.3559352 · Cited by 133 · see citing works
PLANET: A Multi-objective Graph Neural Network Model for Protein–Ligand Binding Affinity Prediction
Zhang, X., Gao, H., Wang, H., Chen, Z., Zhang, Z., Chen, X., Li, Y., Qi, Y., & Wang, R. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00253 · Cited by 133 · see citing works
Machine learning methods, databases and tools for drug combination prediction
Wu, L., Wen, Y., Leng, D., Zhang, Q., Dai, C., Wang, Z., Liu, Z., Yan, B., Zhang, Y., Wang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab355 · Cited by 131 · see citing works
Yazdani-Jahromi, M., Yousefi, N., Tayebi, A., Kolanthai, E., Neal, C. J., Seal, S., & Garibay, Ö. Ö. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac272 · Cited by 125 · see citing works
Yang, Z., Zhong, W., Lv, Q., Dong, T., & Chen, C. Y. (2023) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.2c03906 · Cited by 123 · see citing works
Wang, Z., Zheng, L., Liu, Y., Qu, Y., Li, Y., Zhao, M., Mu, Y., & Li, W. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.753002 · Cited by 118 · see citing works
A review on compound-protein interaction prediction methods: Data, format, representation and model
Lim, S., Lu, Y., Cho, C. Y., Sung, I., Kim, J.-W., Kim, Y., Park, S., & Kim, S. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.03.004 · Cited by 116 · see citing works
Son, J., & Kim, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249404 · Cited by 114 · see citing works
Jain, S., Siramshetty, V. B., Alves, V. M., Muratov, E. N., Kleinstreuer, N., Tropsha, A., Nicklaus, M. C., Simeonov, A. M., & Zakharov, A. V. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01164 · Cited by 114 · see citing works
Drug-drug interactions prediction based on deep learning and knowledge graph: A review
Luo, H., Yin, W., Wang, J., Zhang, G., Liang, W., Luo, J., & Yan, C. (2024) · iScience · doi:10.1016/j.isci.2024.109148 · Cited by 111 · see citing works
3D Infomax improves GNNs for Molecular Property PredictionPreprint
Stärk, H., Beaini, D., Corso, G., Tossou, P., Dallago, C., Günnemann, S., & Lió, P. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2110.04126 · Cited by 110 · see citing works
Critical assessment of AI in drug discovery
Walters, W. P., & Barzilay, R. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1915982 · Cited by 108 · see citing works
kGCN: a graph-based deep learning framework for chemical structures
Kojima, R., Ishida, S., Ohta, M., Iwata, H., Honma, T., & Okuno, Y. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00435-6 · Cited by 106 · see citing works
GraphDTA: Predicting drug–target binding affinity with graph neural networksPreprint
Nguyen, T., Le, H., Quinn, T. P., Nguyen, T., Le, T. D., & Venkatesh, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/684662 · Cited by 103 · see citing works
Artificial Intelligence to Accelerate the Discovery of N 2 Electroreduction Catalysts
Kim, M., Yeo, B. C., Park, Y., Lee, H. M., Han, S. S., & Kim, D.-H. (2019) · Chemistry of Materials · doi:10.1021/acs.chemmater.9b03686 · Cited by 101 · see citing works
Protein Docking Model Evaluation by Graph Neural Networks
Wang, X., Flannery, S. T., & Kihara, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.647915 · Cited by 100 · see citing works
Graph Neural Networks for Molecules
Wang, Y., Li, Z., & Farimani, A. B. (2023) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-031-37196-7_2 · Cited by 100 · see citing works
Geometric deep learning for drug discovery
Liu, M., Li, C., Chen, R., Cao, D., & Zeng, X. (2023) · Expert Systems with Applications · doi:10.1016/j.eswa.2023.122498 · Cited by 98 · see citing works
Ali, R. S. A. E., Meng, J., Khan, M. E. I., & Jiang, X. (2024) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2024.100049 · Cited by 98 · see citing works
Toward Subgraph-Guided Knowledge Graph Question Generation With Graph Neural Networks
Chen, Y., Wu, L., & Zaki, M. J. (2023) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2023.3264519 · Cited by 98 · see citing works
Zhou, D., Xu, Z., Li, W., Xie, X., & Peng, S. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab473 · Cited by 95 · see citing works
Stealing Links from Graph Neural NetworksPreprint
He, X., Jia, J., Michael Backes, A., Gong, N. Z., & Zhang, Y. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2005.02131 · Cited by 94 · see citing works
GEFA: Early Fusion Approach in Drug-Target Affinity Prediction
Nguyen, T. M., Nguyen, T., Le, T. M., & Tran, T. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3094217 · Cited by 91 · see citing works
McInnes, G., Sharo, A. G., Koleske, M. L., Brown, J. E. H., Norstad, M., Adhikari, A. N., Wang, S., Brenner, S. E., Halpern, J., Koenig, B. A., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.03.003 · Cited by 86 · see citing works
Self-citationAI in drug development: a multidisciplinary perspective
Gallego, V., Naveiro, R., Roca, C., Insua, D. R., & Campillo, N. E. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10266-8 · Cited by 86 · see citing works
Effective drug–target interaction prediction with mutual interaction neural network
Li, F., Zhang, Z., Guan, J., & Zhou, S. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac377 · Cited by 86 · see citing works
DDI-GCN: Drug-drug interaction prediction via explainable graph convolutional networks
Zhong, Y., Zheng, H., Chen, X., Zhao, Y., Gao, T., Dong, H., Luo, H., & Weng, Z. (2023) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2023.102640 · Cited by 85 · see citing works
A point cloud-based deep learning strategy for protein–ligand binding affinity prediction
Wang, Y., Wu, S., Duan, Y., & Huang, Y. P. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab474 · Cited by 81 · see citing works
Shen, C., Zhang, X., Hsieh, C., Deng, Y., Wang, D., Xu, L., Wu, J., Li, D., Kang, Y., Hou, T., et al. (2023) · Chemical Science · doi:10.1039/d3sc02044d · Cited by 80 · see citing works
PASSer: prediction of allosteric sites server
Tian, H., Jiang, X., & Tao, P. (2021) · Machine Learning Science and Technology · doi:10.1088/2632-2153/abe6d6 · Cited by 78 · see citing works
GraphDTA: Predicting drug target binding affinity with graph neural networks
Nguyen, T., (13305396), H. L., Quinn, T. P., Nguyen, T. M., (14461665), T. L., & Venkatesh, S. (2024) · Figshare · Cited by 74 · see citing works
Deep learning in target prediction and drug repositioning: Recent advances and challenges
Yu, J., Dai, Q.-Q., & Li, G. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.010 · Cited by 74 · see citing works
Predicting Protein–Ligand Docking Structure with Graph Neural Network
Jiang, H., Wang, J., Cong, W., Huang, Y., Ramezani, M., Sarma, A., Dokholyan, N. V., Mahdavi, M., & Kandemir, M. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00127 · Cited by 74 · see citing works
Compound–protein interaction prediction by deep learning: Databases, descriptors and models
Du, B.-X., Qin, Y., Jiang, Y., Xu, Y., Yiu, S., Yu, H., & Shi, J. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.02.023 · Cited by 73 · see citing works
Drug-Target Interaction Prediction: End-to-End Deep Learning Approach
Monteiro, N. R. C., Ribeiro, B., & Arrais, J. P. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.2977335 · Cited by 70 · see citing works
Connecting chemistry and biology through molecular descriptors
Fernández‐Torras, A., Comajuncosa-Creus, A., Duran‐Frigola, M., & Aloy, P. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.09.001 · Cited by 70 · see citing works
Structure‐Based Drug Discovery with Deep Learning**
Özçelik, R., van Tilborg, D., Jiménez-Luna, J., & Grisoni, F. (2023) · ChemBioChem · doi:10.1002/cbic.202200776 · Cited by 69 · see citing works
ChemBO: Bayesian Optimization of Small Organic Molecules with Synthesizable RecommendationsPreprint
Korovina, K., Xu, S., Kandasamy, K., Neiswanger, W., Póczos, B., Schneider, J., & Xing, E. P. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1908.01425 · Cited by 69 · see citing works
A review of deep learning methods for ligand based drug virtual screening
Wu, H., Liu, J., Zhang, R., Lu, Y., Cui, G., Cui, Z., & Ding, Y. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.02.011 · Cited by 67 · see citing works
Augmented base pairing networks encode RNA-small molecule binding preferences
Oliver, C., Mallet, V., Sarrazin‐Gendron, R., Reinharz, V., Hamilton, W. L., Moitessier, N., & Waldispühl, J. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa583 · Cited by 66 · see citing works
Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts
Karimi, M., Wu, D., Wang, Z., & Shen, Y. (2019) · doi:10.1101/2019.12.28.890103 · Cited by 64 · see citing works
Predicting Drug–Target Interactions with Deep-Embedding Learning of Graphs and Sequences
Chen, W., Chen, G., Zhao, L., & Chen, C. Y. (2021) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.1c02419 · Cited by 64 · see citing works
Explainable Deep Relational Networks for Predicting Compound–Protein Affinities and Contacts
Karimi, M., Wu, D., Wang, Z., & Shen, Y. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00866 · Cited by 64 · see citing works
De Novo Structure-Based Drug Design Using Deep Learning
Krishnan, S. R., Bung, N., Vangala, S. R., Srinivasan, R., Bulusu, G., & Roy, A. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01319 · Cited by 63 · see citing works
Studying Noncovalent Interactions in Molecular Systems with Machine Learning
Tretiakov, S., Nigam, A., & Pollice, R. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00893 · Cited by 63 · see citing works
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18091271 · Cited by 61 · see citing works
Zhou, C., Zhong-zheng, L., Song, J. L., & Xiang, W. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.108003 · Cited by 60 · see citing works
Liao, J., Chen, H., Wei, L., & Wei, L. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106145 · Cited by 57 · see citing works
Yan, X., Zhang, J., Russo, D. P., Zhu, H., & Yan, B. (2020) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.0c07453 · Cited by 57 · see citing works
Using graph convolutional neural networks to learn a representation for glycans
Burkholz, R., Quackenbush, J. F., & Bojar, D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109251 · Cited by 56 · see citing works
Příhoda, D., Maritz, J. M., Klempíř, O., Džamba, D., Woelk, C. H., Hazuda, D. J., Bitton, D. A., & Hannigan, G. D. (2020) · Natural Product Reports · doi:10.1039/d0np00055h · Cited by 55 · see citing works
DrugAI: a multi-view deep learning model for predicting drug–target activating/inhibiting mechanisms
Zhang, S., Yang, K., Liu, Z., Lai, X., Yang, Z., Zeng, J., & Li, S. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac526 · Cited by 52 · see citing works
Huang, Y., Wuchty, S., Zhou, Y., & Zhang, Z. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad020 · Cited by 51 · see citing works
Recent Developments in Ultralarge and Structure-Based Virtual Screening Approaches
Gorgulla, C. (2023) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-020222-025013 · Cited by 50 · see citing works
Yang, Z., Zhong, W., Lv, Q., Dong, T., Chen, G., & Chen, C. Y. (2024) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2024.3400515 · Cited by 48 · see citing works
COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
Senger, M. R., Evangelista, T. C. S., Dantas, R. F., Santana, M. V., Gonçalves, L. C. S., Neto, L. R. D. S., Ferreira, S. B., & Silva, F. P. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760200254 · Cited by 47 · see citing works
GanDTI: A multi-task neural network for drug-target interaction prediction
Wang, S., Shan, P., Zhao, Y., & Zuo, L. (2021) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2021.107476 · Cited by 47 · see citing works
Li, B., Su, S., Zhu, C., Lin, J., Hu, X., Su, L., Yu, Z., Liao, K., & Chen, H. (2023) · Journal of Cheminformatics · doi:10.1186/s13321-023-00732-w · Cited by 46 · see citing works
Drug-target interaction/affinity prediction: Deep learning models and advances review
Vefghi, A., Rahmati, Z., & Akbari, M. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110438 · Cited by 46 · see citing works
Zhao, B.-W., You, Z., Hu, L., Guo, Z.-H., Wang, L., Chen, Z., & Wong, L. (2021) · Cancers · doi:10.3390/cancers13092111 · Cited by 45 · see citing works
Janela, T., & Bajorath, J. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00581-6 · Cited by 44 · see citing works
Machine learning small molecule properties in drug discovery
Schapin, N., Majewski, M., Varela‐Rial, A., Arróniz, C., & Fabritiis, G. D. (2023) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2023.100020 · Cited by 44 · see citing works
Machine learning for drug repositioning: Recent advances and challenges
Cai, L., Chu, J., Xu, J., Meng, Y., Lu, C., Tang, X., Wang, G., Tian, G., & Yang, J. (2023) · Current Research in Chemical Biology · doi:10.1016/j.crchbi.2023.100042 · Cited by 43 · see citing works
He, H., Chen, G., Tang, Z., & Chen, C. Y. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01464-x · Cited by 43 · see citing works
- Authors
- Torng, W., & Altman, R. B.
- Affiliations
- Stanford University (US)
- Corresponding author
- Torng, Wen
- Altman, Russ B.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-10-03
- Volume
- 59
- Issue
- 10
- Pages
- 4131-4149
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W2978484973
- Cited by
- 371
- References
- 56
- Citations by year
- 2026: 25 · 2025: 54 · 2024: 55 · 2023: 63 · 2022: 59 · 2021: 72 · 2020: 35 · 2019: 6
- FWCI
- 29.27
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Journal of Chemical Information and Modeling (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services (GM102365)
- National Science Foundation (ACI-1429830)
- Chan-Zuckerberg Biohub
- Siebel Scholar Foundation
- Topics
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- drug-target interaction prediction, protein-ligand binding, graph convolutional networks, graph autoencoder, virtual screening, binding affinity prediction
- MeSH terms
- Drug Development, Binding Sites, Ligands, Protein Binding, Protein Conformation, Proteins, Neural Networks, Computer, Drug Discovery, Databases, Chemical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review